FDA Panel Rejects Experimental Weight Loss Pill

Published July 15, 2010

FDA panel rejects experimental weight loss pill
A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects outweigh its ability to help patients lose weight.
Read more on AP via Yahoo! News

FDA Panel Says ‘No’ to Weight Loss Drug Qnexa
An FDA advisory panel voted against approval of the weight loss drug Qnexa because of potential side effects.
Read more on WebMD

FDA Rejects S.Bay Drugmaker’s New Weight Loss Pill
A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects outweigh its ability to help patients lose weight. The Food and Drug Administration panel voted 10-6 against Vivus’s Qnexa, citing uncertainty about the potential risks that could come with long-term use of the drug. The FDA will consider …
Read more on CBS 5 Bay Area